文献库，生知库 | 链接生命科学的每一步

日期影响因子

Daratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414)

Daratumumab 联合 Atezolizumab 治疗既往接受过治疗的晚期或转移性 NSCLC：一项随机、开放标签、1b/2 期研究的简要报告 (LUC2001 JNJ-54767414)

期刊:JTO Clinical and Research Reports

影响因子:3.5

doi:10.1016/j.jtocrr.2020.100104

Pillai, Rathi N; Ramalingam, Suresh S; Thayu, Meena; Lorenzini, Patricia; Alvarez Arias, Diana A; Moy, Christopher; Hutnick, Natalie; Knoblauch, Roland; Feng, Huaibao; Kane, Colleen; Horn, Leora; Reck, Martin; Ponce, Santiago

发表日期：2021

文献求助收藏

Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis

肺部立体定向放射治疗联合免疫治疗：一项多中心安全性和毒性分析

期刊:International Journal of Radiation Oncology Biology Physics

影响因子:6.5

doi:10.1016/j.ijrobp.2019.12.030

Tian, Sibo; Switchenko, Jeffrey M; Buchwald, Zachary S; Patel, Pretesh R; Shelton, Joseph W; Kahn, Shannon E; Pillai, Rathi N; Steuer, Conor E; Owonikoko, Taofeek K; Behera, Madhusmita; Curran, Walter J; Higgins, Kristin A

免疫/内分泌

发表日期：2020

文献求助收藏

Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis

三联疗法治疗III期N2阳性非小细胞肺癌：一项基于国家癌症数据库的分析

期刊:Oncologist

影响因子:4.2

doi:10.1634/theoncologist.2019-0661

Behera, Madhusmita; Steuer, Conor E; Liu, Yuan; Fernandez, Felix; Fu, Chao; Higgins, Kristin A; Gillespie, Theresa W; Pakkala, Suchita; Pillai, Rathi N; Force, Seth; Belani, Chandra P; Khuri, Fadlo R; Curran, Walter J; Ramalingam, Suresh S

细胞生物学

发表日期：2020

文献求助收藏

Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy

肌少症和全身炎症对接受免疫疗法治疗的晚期癌症患者生存率的联合影响

期刊:Oncologist

影响因子:4.2

doi:10.1634/theoncologist.2019-0751

Bilen, Mehmet Asim; Martini, Dylan J; Liu, Yuan; Shabto, Julie M; Brown, Jacqueline T; Williams, Milton; Khan, Amir I; Speak, Alexandra; Lewis, Colleen; Collins, Hannah; Kissick, Haydn T; Carthon, Bradley C; Akce, Mehmet; Shaib, Walid L; Alese, Olatunji B; Pillai, Rathi N; Steuer, Conor E; Wu, Christina S; Lawson, David H; Kudchadkar, Ragini R; El-Rayes, Bassel F; Ramalingam, Suresh S; Owonikoko, Taofeek K; Harvey, R Donald; Master, Viraj A

Immunology/Inflammation

免疫/内分泌

发表日期：2020

文献求助收藏

Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience

转移性KRAS突变肺腺癌患者的特征和预后：肺癌突变联盟的经验

期刊:Journal of Thoracic Oncology

影响因子:20.8

doi:10.1016/j.jtho.2019.01.020

El Osta, Badi; Behera, Madhusmita; Kim, Sungjin; Berry, Lynne D; Sica, Gabriel; Pillai, Rathi N; Owonikoko, Taofeek K; Kris, Mark G; Johnson, Bruce E; Kwiatkowski, David J; Sholl, Lynette M; Aisner, Dara L; Bunn, Paul A; Khuri, Fadlo R; Ramalingam, Suresh S

发表日期：2019

文献求助收藏

Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials

晚期癌症患者在接受序贯免疫疗法治疗的 I 期临床试验中的临床结果

期刊:Investigational New Drugs

影响因子:2.7

doi:10.1007/s10637-019-00736-0

Martini, Dylan J; Liu, Yuan; Shabto, Julie M; Lewis, Colleen; Kline, Meredith R; Collins, Hannah; Akce, Mehmet; Kissick, Haydn T; Carthon, Bradley C; Shaib, Walid L; Alese, Olatunji B; Pillai, Rathi N; Steuer, Conor E; Wu, Christina S; Lawson, David H; Kudchadkar, Ragini R; Master, Viraj A; El-Rayes, Bassel F; Ramalingam, Suresh S; Owonikoko, Taofeek K; Harvey, R Donald; Bilen, Mehmet Asim

免疫/内分泌

发表日期：2019

文献求助收藏

Health care disparities among octogenarians and nonagenarians with stage III lung cancer

八十岁以上患有III期肺癌的老人所面临的医疗保健差异

影响因子:5.1

doi:10.1002/cncr.31077

Cassidy, Richard J; Zhang, Xinyan; Switchenko, Jeffrey M; Patel, Pretesh R; Shelton, Joseph W; Tian, Sibo; Nanda, Ronica H; Steuer, Conor E; Pillai, Rathi N; Owonikoko, Taofeek K; Ramalingam, Suresh S; Fernandez, Felix G; Force, Seth D; Gillespie, Theresa W; Curran, Walter J; Higgins, Kristin A

发表日期：2018

文献求助收藏

Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature

非小细胞肺癌中PD-1抑制剂与PD-L1抑制剂毒性特征的比较：文献系统分析

影响因子:5.1

doi:10.1002/cncr.31043

Pillai, Rathi N; Behera, Madhusmita; Owonikoko, Taofeek K; Kamphorst, Alice O; Pakkala, Suchita; Belani, Chandra P; Khuri, Fadlo R; Ahmed, Rafi; Ramalingam, Suresh S

细胞生物学

发表日期：2018

文献求助收藏

Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.

肺癌患者接受 PD-1 靶向治疗后外周血中 PD-1+ CD8 T 细胞的增殖

期刊:Proceedings of the National Academy of Sciences of the United States of America

影响因子:9.1

doi:10.1073/pnas.1705327114

Kamphorst Alice O, Pillai Rathi N, Yang Shu, Nasti Tahseen H, Akondy Rama S, Wieland Andreas, Sica Gabriel L, Yu Ke, Koenig Lydia, Patel Nikita T, Behera Madhusmita, Wu Hong, McCausland Megan, Chen Zhengjia, Zhang Chao, Khuri Fadlo R, Owonikoko Taofeek K, Ahmed Rafi, Ramalingam Suresh S

细胞生物学

发表日期：2017

文献求助收藏

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium

肺腺癌中的 HER2 突变：肺癌突变联盟的报告

影响因子:5.1

doi:10.1002/cncr.30869

Pillai, Rathi N; Behera, Madhusmita; Berry, Lynne D; Rossi, Mike R; Kris, Mark G; Johnson, Bruce E; Bunn, Paul A; Ramalingam, Suresh S; Khuri, Fadlo R

发表日期：2017

文献求助收藏